Poll Results: USMCA Trade Agreement

U.S. voters are concerned that the proposed new trade agreement with Mexico and Canada (USMCA) will negatively impact drug prices and access to generics.

See the Poll Results
Join the Movement

Let's fix the proposed new trade agreement with Mexico and Canada (USMCA) and work together to lower drug prices for patients. Send a message to your elected representatives now!

Take Action
Meet Your Industry Peers

Access! 2019 is marching into New Orleans, February 4-6. Bolster your position in the market as a thought leader and network with those shaping the generics and biosimilars industry.

Register Now
Generic Drugs are the Prescription for Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Patients Can See Their Savings

For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.

Learn More
Preserve Patient Access in Trade Agreements

The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Learn More
Skyrocketing Drug Prices are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Preserve Patient Access in USMCA

Nov 14, 2018 | Rachel Schwartz

Poll Results: Americans’ Attitudes on U.S. Trade Policy and Drug Pricing

Patient Groups, Retirees, American Workers, Doctors, Manufacturers, Join to Voice Concern Over Proposed Trade Deal

Nov 5, 2018 | Rachel Schwartz

Patient Groups, Retirees, American Workers, Doctors, Manufacturers, Join to Voice Concern Over Proposed Trade Deal

Prescription Drug Safety: Education and Impact

Oct 30, 2018 | Chip Davis

Prescription Drug Safety: Education and Impact

Women in Health Policy Happy Hour October 2018

Oct 29, 2018 | Kristin Murphy

Women in Health Policy Gather at AAM

AAM Amicus Brief

Oct 17, 2018 | Jeff Francer

HELSINN v. TEVA

Supreme Court

Oct 17, 2018 | Rachel Schwartz

AAM Files Amicus Brief in Helsinn v Teva